Intrinsic Value of S&P & Nasdaq Contact Us

Replimune Group, Inc. REPL

NASDAQ Global Select

SharesGrow Score
51/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.75
+605.1%

Replimune Group, Inc. (REPL) current share price is $1.95. The gold spot price is $4,825.20 per troy ounce. Using the formula: REPL in gold = $1.95 × 31.1035 ÷ $4,825.20 = 0.0126 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of REPL when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding REPL shares over the measured period.

REPL in US Dollars
Gold in US Dollars
REPL in Gold (grams per share)

Real Wealth Growth Rate

REPL
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{REPL}_{\text{gold}}(t) = \frac{P_{\text{REPL}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{REPL}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{REPL}_{\text{gold}}^{(T)}}{\text{REPL}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{REPL}_\text{gold}^{(0)}$ = initial gold-price, $\text{REPL}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

UTHR
UTHR
United Therapeutics Corporation
$578.54
+0.16%
ASND
ASND
Ascendis Pharma A/S
$249.84
+0.52%
CERE
CERE
Cerevel Therapeutics Holdings, Inc.
$44.96
+0.74%
NUVL
NUVL
Nuvalent, Inc.
$105.02
+1.28%
MRUS
MRUS
Merus N.V.
$90.00
+0.00%
PTGX
PTGX
Protagonist Therapeutics, Inc.
$104.72
+7.33%
CRNX
CRNX
Crinetics Pharmaceuticals, Inc.
$39.75
+2.82%
NAMS
NAMS
NewAmsterdam Pharma Company N.V.
$34.44
-4.99%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message